drug launches

18% of Indian pharma launches to be delayed in US, says Crisil
18% of Indian pharma launches to be delayed in US, says Crisil
Economic Times, India
India
drug launches
FDA
Flag link:
JPM: New Novartis pharma chief rethinks its drug-launch formula
JPM: New Novartis pharma chief rethinks its drug-launch formula
Fierce Pharma
Novartis
Pharma CEOs
Vas Narasimhan
drug launches
JPMHC 2020
Flag link:
5 biotech trends to follow in 2020
5 biotech trends to follow in 2020
BioPharma Dive
biotech
M&A
drug launches
JPMHC 2020
Flag link:
3 Blockbuster Cancer Drug Launches to Watch in 2020
3 Blockbuster Cancer Drug Launches to Watch in 2020
Motley Fool
FDA
drug approvals
cancer
drug launches
AstraZeneca
Enhertu
Padcev
Seattle Genetics
BeiGene
Brukinsa
Flag link:
Eisai preps for launch with insomnia med Dayvigo after buying out Purdue
Eisai preps for launch with insomnia med Dayvigo after buying out Purdue
Fierce Pharma
Eisai
Purdue
FDA
drug launches
insomnia
Dayvigo
Flag link:
Drug Launch of the Year: Zolgensma
Drug Launch of the Year: Zolgensma
Biopharma Dive
drug launches
Novartis
Zolgensma
SMA
Flag link:
AbbVie's new launches Skyrizi, Rinvoq aren't getting enough credit: analyst
AbbVie's new launches Skyrizi, Rinvoq aren't getting enough credit: analyst
Fierce Pharma
AbbVie
Skyrizi
Rinvoq
Allergan
drug launches
Flag link:
Intercept aims to triple sales force as it gears up for potential NASH launch
Intercept aims to triple sales force as it gears up for potential NASH launch
Fierce Pharma
Intercept Pharma
hirings
drug reps
NASH
drug launches
Ocaliva
obeticholic acid
Flag link:
Sage's new drug starts slow, as Wall Street waits for depression data
Sage's new drug starts slow, as Wall Street waits for depression data
Biopharma Dive
SAGE Therapeutics
postpartum depression
Zulresso
drug launches
Flag link:
Pfizer's heart drug impresses with fast US launch
Pfizer's heart drug impresses with fast US launch
Biopharma Dive
Pfizer
drug launches
Vyndaqel
ATTR-CM
Flag link:
Sun Pharma launches CEQUA for treatment of dry eye disease in US
Sun Pharma launches CEQUA for treatment of dry eye disease in US
Pharmaceutical Business Review
Sun Pharma
dry eye disease
Cequa
drug launches
Flag link:
2 Biotechs With Approaching Drug Approvals
2 Biotechs With Approaching Drug Approvals
Motley Fool
drug approvals
drug launches
FDA
voxelotor
Global Blood Therapeutics
Immunomedics
sacituzumab govitecan
Flag link:
bluebird bio Prepares for Launch
bluebird bio Prepares for Launch
Motley Fool
Bluebird Bio
Zynteglo
beta-thalassemia
drug launches
Flag link:
FDA-approved Humira copycat from Merck, Samsung Bioepis will wait 4 years to launch
FDA-approved Humira copycat from Merck, Samsung Bioepis will wait 4 years to launch
Endpoints
Merck
Samsung Bioepis
FDA
Humira
AbbVie
drug launches
biosimilars
Flag link:
Pfizer's keys to juggling 8 U.S. launches? Organization, accountability, clear goals
Pfizer's keys to juggling 8 U.S. launches? Organization, accountability, clear goals
Fierce Pharma
Pfizer
oncology
drug launches
biosimilars
Flag link:
Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap
Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap
Fierce Pharma
Novartis
Mylan
Pfizer
EpiPens
Sandoz
Symjepi
drug launches
Adamis Pharmaceuticals
Flag link:
First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants
First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants
Drug Patent Watch
generics
drug launches
Flag link:
Catalyst Pharma Focuses on Firdapse Launch & Label Expansion
Catalyst Pharma Focuses on Firdapse Launch & Label Expansion
Yahoo/Zacks.com
Catalyst Pharma
Firdapse
drug launches
LEMS
Flag link:
Eyeing a drug launch in early ’20, Esperion lines up a new, $200M funding deal
Eyeing a drug launch in early ’20, Esperion lines up a new, $200M funding deal
Endpoints
Esperion Therapeutics
bempadoic acid
drug launches
Flag link:
AbbVie's discounting Humira to aid Skyrizi's launch—and a price war could follow: analyst
AbbVie's discounting Humira to aid Skyrizi's launch—and a price war could follow: analyst
Fierce Pharma
AbbVie
Humira
Skyrizi
drug launches
psoriasis
drug pricing
formulary
Flag link:

Pages